New and emerging therapies in infectious diseases.
Infectious diseases account for one-third of all deaths worldwide. The last decade has yielded significant advances in the treatment of infectious skin diseases. This article highlights emerging therapies for viral, fungal, bacterial, and parasitic skin cutaneous infections.
Harris
B D
BD
Department of Dermatology, Cleveland Clinic Foundation, Ohio, USA.
Adal
K A
KA
Tomecki
K J
KJ
D000871:Anthelmintics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D016233:Immunotherapy, Active; D007559:Ivermectin / Q000627:therapeutic use; D012874:Skin Diseases, Infectious / Q000628:therapy*; D013792:Thalidomide / Q000627:therapeutic use
D000871:Anthelmintics; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000998:Antiviral Agents; D013792:Thalidomide; D007559:Ivermectin